Tagliabue A, Nencioni L, Villa L, Keren D F, Lowell G H, Boraschi D
Nature. 1983;306(5939):184-6. doi: 10.1038/306184a0.
Secretory antibodies of the IgA class (sIgA) are thought to have an important role in the defence against bacteria at mucosal surfaces--the level at which the infectious agents first come into contact with the host. However, the mechanism by which sIgA exert their antibacterial activity is still a matter of debate. After the recent discovery of receptors for the Fc portion of IgA (RFc alpha) on lymphocytes, monocytes and granulocytes of human, rabbit, guinea pig and mouse origin, it has been hypothesized that IgA also mediate antibody-dependent cellular cytotoxicity (ADCC). Indeed, ADCC mediated by human leukocytes against bacteria has been demonstrated in the presence of human circulating IgA. As RFc alpha have also been shown to bind sIgA, we decided to investigate whether sIgA could mediate antibacterial ADCC when bound to lymphocytes from the murine gut-associated lymphoid tissues (GALT) which first interact with the invading bacteria. By using Shigella X16 (a hybrid strain between the enteric pathogen Shigella flexneri and Escherichia coli) as target in an in vitro assay that measures cell-mediated antibacterial responses, we found that murine lymphocytes from GALT but not from other tissues are able to exert natural antibacterial activity against Shigella X16, and that sIgA significantly and specifically increase the natural antibacterial activity of GALT lymphocytes from mice and induce antibacterial activity in cells from the spleen, but not from the thymus or popliteal lymph nodes. Thus, we now propose a new role for sIgA in protecting the host against infectious agents at the mucosal level.
IgA类分泌型抗体(sIgA)被认为在黏膜表面抵御细菌方面发挥着重要作用,黏膜表面是感染因子首次与宿主接触的层面。然而,sIgA发挥抗菌活性的机制仍存在争议。在最近发现人、兔、豚鼠和小鼠来源的淋巴细胞、单核细胞和粒细胞上存在IgA Fc段受体(RFcα)之后,有人提出IgA也介导抗体依赖性细胞毒性(ADCC)。事实上,在人循环IgA存在的情况下,已证明人白细胞介导的针对细菌的ADCC。由于RFcα也已被证明能结合sIgA,我们决定研究当sIgA与首先与入侵细菌相互作用的小鼠肠道相关淋巴组织(GALT)中的淋巴细胞结合时,是否能介导抗菌ADCC。通过在一项测量细胞介导抗菌反应的体外试验中使用志贺氏菌X16(肠道病原体福氏志贺菌和大肠杆菌之间的杂交菌株)作为靶标,我们发现来自GALT而非其他组织的小鼠淋巴细胞能够对志贺氏菌X16发挥天然抗菌活性,并且sIgA显著且特异性地增强了来自小鼠GALT淋巴细胞的天然抗菌活性,并在脾脏细胞而非胸腺或腘淋巴结细胞中诱导出抗菌活性。因此,我们现在提出sIgA在黏膜水平保护宿主免受感染因子侵害方面的新作用。